Our Members
As a member-focused Association, our members are at the heart of everything we do at the PRI.
In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.
Find out more about the different ways you and your organization can get involved with the PRI’s activities.
- Microbiome Regulatory Science Support Work
- Pre-competitive Task Groups
- Year-round networking and project-related communication support
PRI Members represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.
DTU Biosustain
Jen Kindtler
VP Research and Development
ETH Zurich
Christophe Lacroix
Professor
Public university
everImmune
Cyrille Jeune
COO (interim)
everImmune leverages the potential of the gut microbiota for the development of therapeutic (Oncobax®) and diagnosis tools in cancer.
Ferring Pharmaceuticals
Adam Jarlfors
Global Regulatory Lead
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives.
FNRS UCLouvain – Metabolism & Nutrition (MNUT)
Amandine Everard
Professor
Academic research in microbiome at University (Univeristé Catholique de Louvain - UCL)
Freya Biosciences
Johan E.T. van Hylckama Vlieg
CSO & Co-founder
Freya™ is a clinical-stage company taking an innovative approach to women’s health, with microbial immunotherapies aimed at relieving the chronic inflammation underlying a range of reproductive system diseases uniquely afflicting women.
GenoScreen
Nelly Badalato
R&D Manager
GenoScren is a French biotech with 20+ years of expertise – we develop cutting-edge end-to-end analytical solutions to decipher microbiome (gut, skin, soil) compositions and functions.
GMT Science
Etienne Formstecher
CEO
GMT Science develops routine, CE-marked microbiome analysis to improve the clinical management of chronic diseases.
